Marc Green - Avacta Group Head Diagnostics

All Insiders . USA . 
Stock . Avacta Group Plc . Stakeholders . Insider . Marc Green
AVCTF Stock  USD 0.78  0.04  4.88%   

Insider

Marc Green is Head Diagnostics of Avacta Group Plc
Phone44 1904 217 070
Webhttps://www.avacta.com

Avacta Group Management Efficiency

The company has return on total asset (ROA) of (0.3162) % which means that it has lost $0.3162 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5633) %, meaning that it generated substantial loss on money invested by shareholders. Avacta Group's management efficiency ratios could be used to measure how well Avacta Group manages its routine affairs as well as how well it operates its assets and liabilities.
Avacta Group Plc has accumulated 1.7 M in total debt with debt to equity ratio (D/E) of 0.04, which may suggest the company is not taking enough advantage from borrowing. Avacta Group Plc has a current ratio of 7.79, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Avacta Group until it has trouble settling it off, either with new capital or with free cash flow. So, Avacta Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avacta Group Plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avacta to invest in growth at high rates of return. When we think about Avacta Group's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Indira NaiduImmutep Limited
N/A
Masanori SawadaHealios KK
N/A
Joel RichardMedinCell SA
N/A
Dennis OlisCresco Labs
60
David HeuzeMedinCell SA
N/A
Michihisa NishiyamaHealios KK
N/A
Deanne LLBImmutep Limited
46
Franck PouzacheMedinCell SA
N/A
Valerie CrosCellectis SA
N/A
Stefan MBABioInvent International AB
60
, MBANorthwest Biotherapeutics
64
Junichi KoteraHealios KK
N/A
Adolfo NoriegaMedinCell SA
N/A
RGN MScBioInvent International AB
N/A
Ingrid TeigeBioInvent International AB
N/A
Malcolm BullClinuvel Pharmaceuticals Ltd
N/A
Cecilia HofvanderBioInvent International AB
56
, LangerPureTech Health plc
74
Kyung NamWortmanCellectis SA
53
Sebastien EnaultMedinCell SA
N/A
Aleksandra MDPureTech Health plc
N/A
Avacta Group Plc offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom, North America, Asia, and rest of Europe. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom. Avacta Group is traded on OTC Exchange in the United States. Avacta Group Plc [AVCTF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Return On Equity-0.56
Return On Asset-0.32

Avacta Group Plc Leadership Team

Elected by the shareholders, the Avacta Group's board of directors comprises two types of representatives: Avacta Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avacta. The board's role is to monitor Avacta Group's management team and ensure that shareholders' interests are well served. Avacta Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avacta Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tony Gardiner, Company CFO
Matt Johnson, Chief Diagnostics
Petros Sarantos, Head Diagnostics
Marc Green, Head Diagnostics
Gemma Wilson, Head Diagnostics
Neil Bell, Chief Therapeutics
Fiona FSB, Chief Division
Michael Vinegrad, Group Director
Emma Wright, Group Counsel
David Smith, CEO Director

Avacta Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Avacta Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.56
Return On Asset-0.32
Operating Margin(3.85) %
Current Valuation332.42 M
Shares Outstanding269.87 M
Shares Owned By Insiders35.05 %
Shares Owned By Institutions13.42 %
Price To Book7.68 X
Price To Sales49.44 X
Revenue2.94 M

Currently Active Assets on Macroaxis

DDDupont De Nemours
CRDOCredo Technology Group
GOOGAlphabet Inc Class C
BACBank of America
CRMSalesforce

Other Information on Investing in Avacta Pink Sheet

Avacta Group financial ratios help investors to determine whether Avacta Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avacta with respect to the benefits of owning Avacta Group security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY